A slower, more gradual dose escalation as is standard practice with GLP-1-based therapies may help mitigate the intensity and duration of tiredness
If all goes according to plan, FDA approval should follow, and marketability by late 2026 or early 2027 could be possible, based on the timelines of other drugs in the category
Dr Natasha Yates, a GP and clinical tutor at Bond University, says its important to remember that most people will regain the weight once they stop taking the drug
Today's Top Deals Fortunatley, telehealth companies exist to make GLP-1 meds more accessible and affordable, while also offering monthly support from qualified medical experts
Related: How weight loss drugs affect your entire body Growth Hormone Secretagogues (CJC-1295, Ipamorelin): Taking this peptide therapy can help the body stimulate the release of its own growth hormone, which may aid in muscle preservation and recovery
Feb 2008;31(2):289-294